PRKN and breast cancer: To understand how PARK2 levels are upregulated by antimicrotubule treatment in breast cancer cells, we predicted putative transcription factors (TF) by overlaying the ChIP-seq data from the ChIP-Atlas database, the UCSC Genome Browser and the virtual laboratory of PROMO (Figure 3C).